purified from certain rat and humantissues and characterized (12, 13, 23). The enzyme isolated from these sources has a molecular mass of 31 kDa, shows maximal activity around neutral pH, requires divalent metal cations (Ca2+ and Mg2+) for activation, and hydrolyzes native DNAto produce oligonucleotides with 5'-phosphoryl and 3'-hydroxy termini (13, 23). Therefore, DNase I differs from deoxyribonuclease II (DNase II), which has an optimal pH of approximately 5.0 and does not require cations for enzymaticactivity. The primary structure of human DNase I slightly differs from that of the rat one. As DNaseI is secreted from exocrine glands such as the pancreas and parotid gland, this enzyme was originally considered to have a digestive function. According to a number of previous reports (12, 22, 23, 30, 31), DNase I is present in a wide variety of tissues, including the kidney, lymph node, small intestine, heart, liver and epididymis, and serum and urine contain appreciable amounts of DNase I (7, 14). Although the enzymatic activity of DNase I is inhibited by monomeric actin (3, 15), the function of this enzyme remains obscure.
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In this study, the expression and distribution of DNaseI in human and rat pituitary cells were examined by the DNase I activity assay, and the reverse transcriptase-polymerase chain reaction (RT-PCR), immunofluorescence, in situ hybridization and immunoelectron microscopy. As a result, we could demonstrate the presence of considerable amounts of DNase I in the hormone-secreting cells of the anterior and intermediate lobes of humanand rat pituitary glands. This is, to our knowledge, the first evidence that endocrine cells synthesize and secrete DNase I exocytotically.
MATERIALS AND METHODS

Tissue preparation
Humantissue samples were obtained from 10 male human bodies during postmortemexaminations with the consent of the bereaved families. The pathological patients, aged 37 to 66 years, had died within 2 weeks after having suffered from myocardial infarction (n = 6), angina (1), subarachonoideal hemorrhage (2), or anaphylactic shock (1). Animal samples were taken from young adult Wistar rats, weighing approximately 180 g, which had been killed by decapitation under ether anesthesia.
Antibo dies
For the humansamples, we used three different polyclonal antibodies which were kindly donated by Drs. K. Kishi and T. Yasuda (Gunma University School of Medicine) and one monoclonal antibody prepared in our laboratory. The characteristics of the polyclonal antibodies used were reported previously (33, 34). The antibodies were as follows: (1) a polyclonal antibody obtained from a rabbit immunized with DNase I pun-fied from human urine, (2) two polyclonal different antibodies obtained from rabbits immunized separately with one of two synthetic peptides of the N-and C-terminal residues of human DNase I, and (3) a monoclonal antibody raised against DNase I purified from human urine. For rat samples, we used two different polyclonal antibodies raised against rat DNase I in our laboratory. These antibodies were obtained from rabbits immunizedseparately with one of two synthetic peptides of the N-and C-terminal residues of rat DNase I.
Immunofluorescenceand in situ hybridization
As described previously (28), the tissues were immersed in a fixative comprising 1% paraformaldehyde and 0.1% picric acid in 0.01 M PBS for 24 hours at 4°C, washed with PBS, immersed in 30% sucrose in phosphate buffered saline (PBS) overnight at 4°C and then frozen rapidly in isopentane cooled with liquid nitrogen. Cryostat sections of 5 fxm thick were cut with a cryostat at -20°C and mountedon glass slides coated with poly-1-lysine. The sections were treated with 1% normal goat serum for 1 hour and then with a polyclonal antibody (1 :500 dilution) with PBS containing 1% bovine serum albumin (BSA) for 24 hours at 4°C. After being washed, the sections were incubated with purified fluorescein isothiocyanate
(1 :500 dilution) for 30 minutes at room temperature, washed, and mounted in 50% glycerol in PBS (pH 8.6) containing 50 mg/ml 1,4-diazabicyclo-actane (DABCO; Aldrich Chemical Co., Milwaukee, WI, USA) as an anti-bleaching agent. For in situ hybridization, the oligonucleotide probe (5 -CTGAAGATCGCAGCCTTCAACATC-3 ') corresponding to the N-terminal region of human DNaseI was labelled with biotin using a biotinylation kit (American Qualex International, Inc., San Clemente, CA, USA). The cryostat sections, prepared as described above, were treated with absolute methanol, dried and permeabilized for 20 minutes at 37°C with predigested proteinase K (1 /^g/ml) in 100 mMTris-HCl, pH 8.0, containing 50 mMEDTA,according to the method reported previously (ll). Negatively charged tissue proteins were blocked in fresh 0.1 M triethanolamine (pH 8.0), containing 0.004% acetic anhydride for 10 minutes. Subsequently, the sections were washedtwice with saline-sodium citrate buffer (SSC) and dehydrated by passage through a graded ethanol series. Hybridization was performed for 3 hours at 37°C in the hybridization buffer consisting of 50% deionized formamide, 10% dextran sulfate, SSC, Denhardt's solution containing 0.02% Ficoll, 0.02% polyvinylpyrolidone, 0.02% BSA, 10 mMdithiothreitol and 0.1 mg/ml denatured salmon sperm DNA.The biotinylated oligonucleotide probe specific to human DNase I was diluted with this hybridization buffer. After hybridization, the sections were washed thoroughly three times with this buffer, treated with FITC-labelled streptavidin for 15 minutes at room temperature. The stained sections were mounted in 50% glycerol-PBS containing 5% DABCO and examined with a fluorescence microscope.
Immunoelectronmicroscopy
Small pieces of tissue were fixed with 1%paraformaldehyde, 0.125% glutaraldehyde and 0A%picric acid in 0.01 M PBS, pH 7.2, at 4°C for 24 hours. Wefound that the routinely used fixatives, particularly glutaraldehyde and osmiumtetroxide (OsO4), dramatically reduced the immunoreactivity of DNase I detected by all antibodies. Therefore, only weak fixation was feasible. After fixation, the tissues were dehydrated with a graded ethanol series at 0°C, embedded in Lowicryl K4Mand thencured for 3 days at -35°C. As described previously (27), ultrathin sections were treated with 3% hydrogen peroxide for 10 minutes and incubated with \% normal goat serum for 1 hour and then with the antirat DNase I antibody (1 :500 dilution) in PBS, pH 7.4, containing \% BSA. After rinsing with PBS, the sections were incubated for 1 hour with 10-nm colloidal gold-labelled anti-rabbit goat immunoglobulin (1 :200 dilution), followed by rinsing with PBSand then distilled water. Finally, the sections were stained with uranyl acetate and lead citrate and examined with a Hitachi H-800 electron microscope (Hitachi, Japan). The specificity of each immunoreaction was confirmed by preabsorption tests involving the addition of excess rat DNaseI to the first antibody.
Assay of tissue DNase I activity DNase I activity was determined using the single radial enzyme diffusion (SRED) method (16). Protein content of the samples was found using a Bio-Rad protein assay kit (BioRad, Hercules, CA, USA)with BSAas the standard.
Detection of human DNase I gene transcripts by PCR The entire procedure used was described in detail in the previous report (30, 32) . In brief, total RNAwas extracted from hu- CTCAGGCCATAG-3', corresponding to the N-and C-terminal portions, respectively, of human DNase I protein was synthesized and used for PCR. After heat denaturation at 90°C for 5 minutes, a 1 (A aliquot of each sample was subjected to PCR analysis. Each DNase I gene transcript was PCR-amplified, and the amplified products were subjected to electrophoresis on a 2% agarose gel. The resulting bands were visualized by ethidium bromide staining.
Immunoblotanalysis
Each tissue specimen was homogenizedin 100 times its volume of sample buffer containing 4%sodium dodecyl sulfate (SDS) and 10% 2-mercaptoethanol, incubated for 5 minutes at 90°C, condensed several times using Centricell (Polyscience, Warrington, PA, USA), and subjected to SDS-polyacrylamide gel electrophoresis (PAGE) on sl 10%acrylamide gradient gel. The proteins were transferred to a nitrocellulose sheet, incubated with monoclonal anti-DNase I antibody
(1 : 10 dilution), the antigens were detected with alkaline phosphatase-conjugated anti-mouse immunoglobulin (1 : 1000 dilution).
RESULT S Specific DNase I activity in various human and rat tis- Immunoblot analysis indicated high levels of DNase I-like immunoreactivity in the humananterior and intermediate pituitary (Fig. 2) , whereas little immunoreactivity was detected in the posterior pituitary. Essentially the sameresults were obtained for the rat pituitary. The presence of DNaseI-specific mRNA was verified by PCR analysis of total RNAextracted from various human tissues. A unique 780-base pair (bp) fragment corresponding to the region encoding the mature enzyme was amplified from total RNAof the human pancreas and the anterior and intermediate pituitary lobes, whereas no amplified product was obtained from RNAs extracted from the brain or posterior lobe (Fig. 3) .
Immunofluorescence indicated very strong immunoreactivity in the cytoplasm of hormone-secreting cells in the anterior and intermediate lobes of humanand rat pituitary glands (Figs. 4A and 5). In contrast, no immunoreactivity was found in the posterior lobe. The immunoreactivity was detected throughout the cytoplasm, but the staining intensity was heterogeneous, being particularly strong in the perinuclear region of the cells. Interestingly, no immunoreactivity was seen in the nuclear region. The staining intensities of pituitary samples differed depending on the antibodies used, but the distribution patterns were basically the same with all antibodies, confirming that DNase I was concentrated in the cytoplasm.
In situ hybridization demonstrated high levels of mRNAspecific to human DNase I in cells of human anterior and intermediate pituitary lobes (Fig. 4B) , but no or only weak immunoreactivity could be detected in the posterior lobe.
Immunoelectron microscopy showed that gold particles were distributed along the secretory pathwayin pituitary endocrine cells of the rat (Fig. 6A, B) In endocrine cells, significant numbers of gold particles were found in secretory granules, Golgi apparatus, and rough-surfaced endoplasmic reticulum (rER), although no or only a few gold particles were seen in the nucleus and mitochondria. Exocytotic granules were also immunopositive as seen in prolactin-secreting cells (Fig. 7) .
DISCUSSION
Immunofluorescence microscopy demonstrated that the hormone-secreting cells in the anterior and intermediate endoplasmic reticulum (rER) in the perinuclear region, whereas only a few particles can be seen in the nucleus and mitochondria (28,000 x ). B; A significant number of gold particles are present in the Golgi cisternae and on vesicles (50,000 x ). N, nucleus; G, Golgi apparatus; M, mitochondria.
pituitary lobes of the humanand rat pituitary were DNase I immunopositive, whereas nonsecretory cells such as folliculo-stellate and ependymal cells were immunonegative. In immunoelectron microscopy, DNase I was distributed along an secretory pathway from rER to exocytotic secretory granules. For immunoelectron microscopy, we fixed tissues samples with very low concentrations of glutaraldehyde without OsO4, because the DNaseI antigenicity was almost completely obliterated by stronger fixatives. Webelieve that this method mayhave application in staining for other cells and tissues.
DNaseI was present in various tissues and cells, such as those of the kidney, lymph node, small intestine, heart, liver, epididymis, and Paneth cells as well as pituitary cells (12, 22, 23, 30, 31, 35) . The wide distribution of DNase I may possibly indicate the functional diversity of this enzyme. DNaseI combines readily with monomeric (G) actin (5, 18, 20, 29) , but the physiological significance of the actin-DNase I interaction remains unclear. Peitsch et al. (18, 19) showed that the nuclease activity responsible for internucleosomal DNAdegradation during apoptosis is functionally indistinguishable from that of DNase I. However, in pituitary cells, this notion maynot be supported by the present finding that DNase I immunoreactivity was limited to the cytoplasm.
The hormone-secreting cells of the intermediate pituitary lobe have been lumped into one group, whose secretory material is limited to melanocyte-stimulating hormone and related peptides, adrenocorticotropin (ACTH)and lipotrophic pituitary hormone. In the present paper, it is interesting to note that all hormone-secreting cells in the anterior pituitary were stained similarly with specific anti-DNase I antibodies. Moreover, there were at least five distinct cell types in the anterior lobe that secrete different hormones: growth hormone, ACTH, prolactin, thyrotropin-releasing hormone, and gonadotropins. Our preliminary experiments in doubleimmunofluorescence failed to demonstrate which cell types were stained more strongly for DNase I. The intensity of DNase I staining appears to reflect the difference in activity of hormonesecretion, rather than cell type. Further investigation is needed to elucidate the relationships between functional diversity and staining intensity.
Though significant amounts of DNase I have been detected in serum and urine (7, 14) , the source of the enzyme in such fluids is unknown. The present results strongly suggest that serum DNase I is possibly produced by endocrine cells, such as those in the pituitary gland. DNase I was distributed mainly along the secretory pathway in pituitary cells. These findings indicated that the enzyme is synthesized in the rER, modified in Golgi apparatus, stored in secretory granules and secreted from the cell membraneexocytotically, probably together with pituitary hormones. In this connection, a recent report by Shak et al. (25) showed the DNA sequence of DNase I possesses a code of signal peptide. This paper supports our finding that DNase I is synthesized in rER at the start of the secretory pathway. Polzar et aL (21) also reported that the transfection of COScells with DNase I CDNAinduces DNase I in a secretory pathway of the cell. In addition to DNaseI, pituitary cells secrete a wide variety ofenzymes (1, 2, 6, 8, 9, 10, 17, 24) , most of which appear to function directly in hormone secretion. One report suggests that DNase I may induce apoptosis of cytotoxic lymphocytes (4). The DNase I secreted from pituitary gland may possibly cause apoptosis of some cells and tissues in rat and human. The correlation between cellular turnover and apoptosis has been reported (18, 19, 21, 22, 31, 35 
